Early post-liver transplant thrombocytopenia in children: Clinical characteristics and significance

Noa Tal1,2, Orith Waisbourd-Zinman2,3, Eytan Kaplan2,4

  • 1Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.

Insights

Post-liver transplant thrombocytopenia is common in children, affecting 89% within 28 days. Low platelet counts correlate with longer intensive care stays, indicating a need for careful monitoring after pediatric liver transplants.

Area of Science:

  • Pediatric Hepatology
  • Transplantation Immunology
  • Hematology

Background:

  • Post-liver transplant thrombocytopenia is a known complication in adults, linked to poorer outcomes.
  • The prevalence, clinical course, and prognostic significance of thrombocytopenia in pediatric liver transplant recipients remain largely undescribed.

Purpose of the Study:

  • To investigate the incidence, characteristics, and clinical implications of thrombocytopenia in children following liver transplantation.

Main Methods:

  • Retrospective analysis of 130 pediatric liver transplant cases performed between 2004 and 2021 at a single tertiary care center.
  • Evaluation of platelet counts, nadir levels, and associated clinical factors within the first 28 days post-transplant.

Main Results:

  • Thrombocytopenia was observed in 89% of pediatric liver transplant recipients within 28 days post-operation (POD).
  • Multivariate analysis identified preoperative platelet count, intraoperative packed red blood cell transfusion volume, and hypersplenism as predictors of lower postoperative platelet counts.
  • A platelet count below the 50th percentile on POD 1 was associated with a more complex postoperative course and prolonged Pediatric Intensive Care Unit (PICU) admission.

Conclusions:

  • Early post-liver transplant thrombocytopenia is highly prevalent in children.
  • Preoperative thrombocytopenia, hypersplenism, and increased intraoperative transfusion requirements are associated with lower postoperative platelet counts.
  • A low platelet count on POD 1 independently predicts a more complicated clinical course, necessitating vigilant monitoring in pediatric liver transplant patients.
Abstract

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
89
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
81
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
66
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
518
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
156